Separate names with a comma.
Discussion in 'Penny Stocks' started by Giants1967, Jun 11, 2020.
OTC Current 6/11.
HALB Company update.
HALB NFL Retired Players Association's Chief Medical Officer Joins Halberd Corporation to Lead #COVID-19 Efforts Effective Immediately! https://finance.yahoo.com/news/nfl-retired-players-associations-chief-120000205.html?.tsrc=fin-srch
Halberd Method for Treating and Curing the COVID-19 Infection Explained
HALB Halberd Corp. Establishes UK Subsidiary - Expands Development of Coronavirus Treatment https://finance.yahoo.com/news/halberd-corp-establishes-uk-subsidiary-120000147.html?soc_src=social-sh&soc_trk=tw via
COVID-19 Cytokine Storm, Coronavirus' Deadliest Stage - Halberd's US Patent Pending Treatment Now Explained! https://finance.yahoo.com/news/covi...s-120000074.html?soc_src=social-sh&soc_trk=tw
HALB Halberd Corp - Update July 13, 2020 - Addresses Certain Issues https://finance.yahoo.com/news/halberd-corp-july-13-2020-120000336.html?soc_src=hl-viewer&soc_trk=tw
Halberd Advances the Treatment of COVID-19 Utilizing Laser Technology https://finance.yahoo.com/news/halberd-advances-treatment-covid-19-120000583.html
HALB Halberd Corporation CTO, Dr. Patricio Reyes, Presents Information at Virtual Event on Covid-19's Effects on Neurological Functions https://finance.yahoo.com/news/halberd-corporation-cto-dr-patricio-120000142.html
HALB Halberd Advances the Treatment of COVID-19 Utilizing Laser Technology
HALB Halberd Corporation Secures $2 Million for Covid-19 Research https://finance.yahoo.com/news/halberd-corporation-secures-2-million-120000110.html
HALB Halberd Corporation Adds Dr. Gregory George as Member of Scientific Advisory Board. *affiliated with the Sharon Regional Health System, part of the Steward Hospital Network, and UPMC Horizon Shenango. https://finance.yahoo.com/news/halberd-corporation-adds-dr-gregory-120000723.html?.tsrc=fin-srch
HALB 8/10/20 Press Release!
Halberd Corporation Adds Dr. Abdon Nanhay to Scientific Advisory Board Furthering the Fight Against Covid-19 Internationally https://finance.yahoo.com/news/halberd-corporation-adds-dr-abdon-120000949.html
Halberd Corp. (OTC PINK:HALB) today announced the addition of Edson Brito to the Scientific Advisory Board. Mr. Brito is CEO and Chief Business Development Officer of Cellybri Advanced Therapies in Brazil. https://finance.yahoo.com/news/halb...o-120000183.html?soc_src=social-sh&soc_trk=tw
Halberd Corporation CEO Answers Shareholders' Questions Regarding Covid-19 Treatment
Halberd Corp. (OTC PINK:HALB) is pleased to announce the successful completion of its search for a major research university partner. The University, to be announced, is engaged to develop compounds for use in Halberd's patented extracorporeal treatment of Covid-19. Terms of the agreement have been finalized and signatures on the contract reflecting the agreed terms, is in process. Details will be released shortly. https://finance.yahoo.com/news/halb...ersity-research-120000489.html?.tsrc=fin-srch
HALB Halberd Selects Arizona State University (ASU) to Develop Its Patented COVID-19 Treatment(s) https://finance.yahoo.com/news/halb...y-120000859.html?soc_src=social-sh&soc_trk=tw
Halberd Corporation (OTC PINK:HALB) today revealed why they selected Arizona State University (ASU) to conduct sponsored research to develop a Covid-19 treatment.
ASU is one of the fastest growing research universities in the country and ranks among the top 10 for Department of Health and Human Services funding among all U.S. institutions without a medical school, placing them ahead of Princeton, Georgia Tech and Carnegie Mellon University. Moreover, U.S. News and World Report named ASU as the most innovative university each year from 2016 -2020, ranking it ahead of such notable institutions as Stanford and MIT.
William A. Hartman, Halberd's Chairman, President & CEO stated, "Before engaging ASU, we reviewed six major universities in the United States. After evaluating all pertinent factors necessary for an institutional research partner, we determined that ASU met all of our criteria. ASU is a highly rated university in research and innovation, and we are fortunate to have them working with us on our project to develop a curative treatment for Covid-19. The efforts will also extend to treatments for other blood-borne and neurologic diseases using our patented extracorporeal treatment process. Halberd seeks a robust treatment beyond coronavirus yielding a pandemic-free society."
HALB 9/8/20 Press!
Halberd Corporation Research on Covid-19 Treatment Development Begins at ASU https://www.otcmarkets.com/stock/HA...Treatment-Development-Begins-at-ASU?id=273157
$HALB The research agreement with Arizona State is out, full contract on company website. https://halberdcorporation.com/wp-content/uploads/2020/09/ASU-K-Fully-Executed.pdf